Skip to main content
. Author manuscript; available in PMC: 2016 Jun 2.
Published in final edited form as: J Thorac Imaging. 2015 Mar;30(2):79–87. doi: 10.1097/RTI.0000000000000136

TABLE 7.

Incremental Cost-effectiveness (Base Case)

Strategy Cost LE QALE Incremental Costs* Incremental Lys Incremental QALYs $/LY 95% CI $/QALY 95% CI
CT $3074 14.7386 10.9692 $1631 0.0316 0.0201 52,000 34,000–106,000 81,000 52,000–186,000
Radiography $1911 14.7071 10.9491 $469 0 0 Dom Dom
None $1443 14.7071 10.9491

Reprinted with permission from Black et al.6

*

Incremental costs are in reference to the None strategy because the Radiography strategy is dominated.

Cost in the None strategy includes diagnosis and treatment of lung cancer without LDCT or radiographic screening.

Dom indicates dominated.